Page last updated: 2024-08-25

rosiglitazone and Carcinoma, Pancreatic Ductal

rosiglitazone has been researched along with Carcinoma, Pancreatic Ductal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balkwill, FR; Bossard, M; Candido, JB; Cook, N; Emami-Shahri, N; Hagemann, T; Maniati, E; Nedospasov, SA; Tuveson, DA	1
Bailey, JM; Bunt, SK; Grandgenett, PM; Hollingsworth, MA; Mohr, AM	1

Other Studies

2 other study(ies) available for rosiglitazone and Carcinoma, Pancreatic Ductal

Article	Year
Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. The Journal of clinical investigation, 2011, Volume: 121, Issue:12 Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Pancreatic Ductal; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, ras; Histones; Homeodomain Proteins; I-kappa B Kinase; Inflammation; Mice; Mice, Inbred C57BL; Neoplasm Proteins; NF-kappa B; Pancreatic Diseases; Pancreatic Neoplasms; Phosphorylation; PPAR gamma; Precancerous Conditions; Protein Processing, Post-Translational; Proto-Oncogene Mas; Receptors, Notch; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor HES-1; Tumor Necrosis Factor-alpha	2011
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer. Cancer immunology, immunotherapy : CII, 2013, Volume: 62, Issue:2 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Humans; Immunosuppression Therapy; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Pioglitazone; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Xenograft Model Antitumor Assays	2013

Article

Year

Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.

The Journal of clinical investigation, 2011, Volume: 121, Issue:12

Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Pancreatic Ductal; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, ras; Histones; Homeodomain Proteins; I-kappa B Kinase; Inflammation; Mice; Mice, Inbred C57BL; Neoplasm Proteins; NF-kappa B; Pancreatic Diseases; Pancreatic Neoplasms; Phosphorylation; PPAR gamma; Precancerous Conditions; Protein Processing, Post-Translational; Proto-Oncogene Mas; Receptors, Notch; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor HES-1; Tumor Necrosis Factor-alpha

2011

Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.

Cancer immunology, immunotherapy : CII, 2013, Volume: 62, Issue:2

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Humans; Immunosuppression Therapy; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Pioglitazone; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Xenograft Model Antitumor Assays

2013